Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages

British Journal of Pharmacology

Volumn 132, Issue 6, 2001, Pages 1349-1357

  Klasen, Stefanie ^a   Hammermann, Rainer ^a   Fuhrmann, Margarita ^a   Lindemann, Dirk ^a   Beck, Karl Friedrich ^b   Pfeilschifter, Josef ^b   Racké, Kurt ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Alveolar macrophages; Arginase; Glucocorticoides; Inducible nitric oxide synthase; Interferon ; Lipopolysaccharides

Indexed keywords

AMPHOTERICIN B; ARGINASE; CYCLOHEXIMIDE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; FEMALE; IMMUNOBLOTTING; LIVER CELL; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035085582     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703951     Document Type: Article

References (47)

1. Molecular mechanisms of glucocorticosteroid actions
2. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: Preferential targetting of NF-kappaB and lack of I-kappaB involvement
3. Inhaled glucocorticoids for asthma
4. Molecular mechanisms of glucocorticoid action in asthma
5. G-hydroxy-L-arginine during high-output NO production
6. Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages
7. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages
8. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B
9. Cloning of rat liver arginase cDNA and elucidation of regulation of arginase gene expression in H4 rat hepatoma cells
10. Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA
11. The glucocorticoid-responsive gene cascade. Activation of the rat arginase gene through induction of C/EBPbeta
12. The delayed glucocorticoid-responsive and hepatoma cell-selective enhancer of the rat arginase gene is located around intron 7
13. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line
14. Regulation of glucocorticoids of arginase and argininosuccinate synthetase in cultured rat hepatoma cells
15. Inability of rat alveolar macrophages to recycle L-citrulline to L-arginine despite induction of argininosuccinate synthetase mRNA and protein, and inhibition of nitric oxide synthesis by exogenous L-citrulline
16. Nuclear factor-κB mediates simultaneously induction of iNOS and upregulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages
17. Molecular cloning and nucleotide sequence of cDNA for human liver arginase
18. G-hydroxy-L-arginine in alveolar macrophages: Implications for the utilization of Larginine for nitric oxide synthesis
19. ω-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase
20. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity
21. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription
22. Cloning and characterization of the mouse and rat type II arginase genes
23. Comparative properties of arginases
24. L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophages
25. Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase
26. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB
27. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
28. Distinct arginase isoforms expressed in primary and transformed macrophages: Regulation by oxygen tension
29. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity
30. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines
31. Human type II arginase: Sequence analysis and tissue-specific expression
32. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
33. Regulation of messenger ribonucleic acid levels for five urea cycle enzymes in cultured rat hepatocytes. Requirements for cyclic adenosine monophosphate, glucocorticoids, and ongoing protein synthesis
34. Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. Both HNF-4 and C/EBP beta are required for liver-specific activity of the ornithine transcarbamylase enhancer
35. Activation of L-arginine transport by protein kinase C in rabbit, rat and mouse alveolar macrophages
36. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages
37. Coinduction of nitricoxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide
38. ωhydroxy-nor-L-arginine on NO synthase activity in murine macrophages
39. Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/enhancer-binding protein alpha, liver activator protein, and D-element-binding protein
40. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
41. Cloning and characterization of the human type II arginase gene
42. Arginase AI is upregulated in acute immune complex-induced inflammation
43. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimutated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in posttranscriptional regulation
44. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide
45. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
46. Arginine metabolism: Nitric oxide and beyond
47. The high-output nitric oxide pathway: Role and regulation